Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 1, 2011, Pages 76-84

  Roeloffzen, Ellen M A ^a   Monninkhof, Evelyn M ^a   Battermann, Jan J ^a   Van Roermund, Joep G H ^a   Moerland, Marinus A ^a   Van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acute urinary retention; Bladder neck; Dosimetry; I 125 Prostate brachytherapy; Urinary morbidity

Indexed keywords

BLADDER NECK; CASE-CONTROL STUDY; DOSIMETRIC PARAMETER; I-125 PROSTATE BRACHYTHERAPY; IN-CONTROL; LOGISTIC REGRESSION ANALYSIS; MULTI VARIATE ANALYSIS; ODDS RATIOS; PROSTATE BRACHYTHERAPY; RISK FACTORS; UNIVARIATE ANALYSIS; URINARY MORBIDITY; URINARY RETENTION;

DOSIMETRY; MAGNETIC RESONANCE IMAGING; MULTIVARIANT ANALYSIS; ONCOLOGY; REGRESSION ANALYSIS; RESONANCE;

RADIOTHERAPY;

IODINE 125;

ADULT; AGED; ARTICLE; BLADDER NECK; BRACHYTHERAPY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RADIATION DOSE; URETHRA; URINE RETENTION;

ACUTE DISEASE; AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; CASE-CONTROL STUDIES; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ODDS RATIO; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RISK ASSESSMENT; URETHRA; URINARY BLADDER; URINARY RETENTION;

EID: 79954423355     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.022     Document Type: Article

References (36)

1. K.A. Hinnen, J.J. Battermann, and J.G. van Roermund Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 2009;Jun 17
2. M.J. Zelefsky, D.A. Kuban, and L.B. Levy Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation Int J Radiat Oncol Biol Phys 67 2007 327 333 (Pubitemid 46108308)
3. L. Potters, C. Morgenstern, and E. Calugaru 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer J Urol 179 2008 S20 S24
4. N.N. Stone, and R.G. Stock Complications following permanent prostate brachytherapy Eur Urol 41 2002 427 433 (Pubitemid 35333940)
5. J.F. Anderson, D.A. Swanson, and L.B. Levy Urinary side effects and complications after permanent prostate brachytherapy: The MD Anderson Cancer Center experience Urology 74 2009 601 605
6. E.M.A. Roeloffzen, I.M. Lips, and M.P.R. Gellekom Health-related quality of life up to six years after I-125 brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 76 2010 1054 1060
7. E.M.A. Roeloffzen, K.A. Hinnen, and J.J. Battermann The impact of acute urinary retention after I-125 prostate brachytherapy on health-related quality of life Int J Radiat Oncol Biol Phys 2009 Epub date, July 7, 2010.
8. M.D. Terk, R.G. Stock, and N.N. Stone Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate J Urol 160 1998 1379 1382 (Pubitemid 29480520)
9. N. Lee, C.S. Wuu, and R. Brody Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 1457 1460
10. J. Bucci, W.J. Morris, and M. Keyes Predictive factors of urinary retention following prostate brachytherapy Int J Radiat Oncol Biol Phys 53 2002 91 98 (Pubitemid 34465811)
11. J. Crook, M. McLean, and C. Catton Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation Int J Radiat Oncol Biol Phys 52 2002 453 460 (Pubitemid 34170850)
12. J. Locke, W. Ellis, and K. Wallner Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study Int J Radiat Oncol Biol Phys 52 2002 712 719 (Pubitemid 34158734)
13. M. Keyes, D. Schellenberg, and V. Moravan Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve? Int J Radiat Oncol Biol Phys 64 2006 825 834 (Pubitemid 43183581)
14. A. Henderson, R.W. Laing, and S.E. Langley Quality of life following treatment for early prostate cancer: Does low dose rate (LDR) brachytherapy offer a better outcome? A review Eur Urol 45 2004 134 141 (Pubitemid 38147817)
15. M. Neill, G. Studer, and L. Le The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry Brachytherapy 6 2007 173 179 (Pubitemid 47187799)
16. Roeloffzen EMA, Battermann JJ, Van Deursen MJH, et al. The influence of dose on the risk of acute urinary retention after I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys [submitted].
17. M.A. Elshaikh, K. Angermeier, and J.C. Ulchaker Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy Urology 61 2003 152 155 (Pubitemid 36151732)
18. S.G. Williams, J.L. Millar, and G.M. Duchesne Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy Radiother Oncol 73 2004 33 38 (Pubitemid 39304122)
19. A. Henderson, A.K. Ismail, and M. Cunningham Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK: A prospective study Clin Oncol 16 2004 95 104 (Pubitemid 38344427)
20. T. Ohashi, A. Yorozu, and K. Toya Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy Jpn J Clin Oncol 36 2006 285 289 (Pubitemid 43997333)
21. M.J. Steggerda, H.G. van der Poel, and L.M. Moonen An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: Bladder hotspot dose and prostate size are significant predictors Radiother Oncol 88 2008 108 114 (Pubitemid 351894940)
22. C. Thomas, M. Keyes, and M. Liu Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 72 2008 447 455
23. Z.A. Allen, G.S. Merrick, and W.M. Butler Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity Int J Radiat Oncol Biol Phys 62 2005 981 987 (Pubitemid 40884407)
24. G.M. Villeirs, L. Verstraete, and W.J. De Neve Magnetic resonance imaging anatomy of the prostate and periprostatic area: A guide for radiotherapists Radiother Oncol 76 2005 99 106 (Pubitemid 41096522)
25. C. Salembier, P. Lavagnini, and P. Nickers Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy Radiother Oncol 83 2007 3 10 (Pubitemid 46527942)
26. A. Trotti The evolution and application of toxicity criteria Semin Radiat Oncol 12 2002 1 3 (Pubitemid 34246061)
27. J.J. Battermann, T.A. Boon, and M.A. Moerland Results of permanent prostate brachytherapy: 13 years of experience at a single institution Radiother Oncol 71 2004 23 28 (Pubitemid 38452898)
28. M.A. Moerland, M.J. van Deursen, and S.G. Elias Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: Comparison between loose and stranded seed implants Radiother Oncol 91 2009 202 206
29. P.W. McLaughlin, S. Troyer, and S. Berri Functional anatomy of the prostate: Implications for treatment planning Int J Radiat Oncol Biol Phys 63 2005 479 491 (Pubitemid 41317165)
30. P.W. McLaughlin, C. Evans, and M. Feng Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy Int J Radiat Oncol Biol Phys 76 2010 369 378
31. J. Crook, A. Toi, and M. McLean The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy Brachytherapy 1 2002 131 137 (Pubitemid 37356898)
32. G.S. Merrick, W.M. Butler, and R.W. Galbreath Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy Urology 57 2001 524 529 (Pubitemid 32192985)
33. M.D. Thomas, R. Cormack, and C.M. Tempany Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy Int J Radiat Oncol Biol Phys 47 2000 905 908 (Pubitemid 30345586)
34. S.J. Buskirk, D.M. Pinkstaff, and S.P. Petrou Acute urinary retention after transperineal template-guided prostate biopsy Int J Radiat Oncol Biol Phys 59 2004 1360 1366 (Pubitemid 38954058)
35. L. Eapen, C. Kayser, and Y. Deshaies Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity Int J Radiat Oncol Biol Phys 59 2004 1392 1394 (Pubitemid 38960765)
36. G.M. Villeirs, and G.O. De Meerleer Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning Eur J Radiol 63 2007 361 368 (Pubitemid 47321042)